Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
Hu CY, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat TD, Suzuki M, Pullman J, Liu XS, Greally JM, Susztak K, Verma A.
Hu CY, et al. Among authors: susztak k.
Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.
Clin Cancer Res. 2014.
PMID: 24916699
Free PMC article.